Drug for abuse are illegal drugs consumed for the non-medication purpose for longer period of time. Drugs of abuse testing is performed both for medical purposes and legal causes such as workplace drug testing. The test for drug for abuse include immunoassay to screen different samples and the confirmation of screening results by definitive analytical techniques such as spectrometry and chromatography. Illicit drugs include cocaine, amphetamines, heroin, and hallucinogens are substances that can inhibit the central nervous system and cause hallucinogenic effects. The key end users in drug for abuse testing market include hospitals, diagnostic laboratories, federal departments, and rehabilitation centers. Some of the other end users are academic institutes and research laboratories.
Market Dynamics
The increasing production and trade of illicit drugs, rise in road accidents and death rates, increase in the consumption of illegal drugs, and growing government initiatives to reduce the incidence of driving under influence of drugs and alcohol are the factors that are driving growth of the market. For instance, according to data by the National Health Services, the number of hospital admissions in England for heroin or other opioid poisoning increased by 121%, since the past 12 years (2006-2018). The number of patients were around 7,258 in the year 2017-2018. Furthermore, According to the press release by Gov. UK in July 2017, the Home Secretary has launched the government’s new drug strategy, to reduce illicit drug use and increase the rate of individuals recovering from drug dependence. The new strategy confronts these threats and sets out new action to protect the most vulnerable, including the homeless, victims of domestic abuse and those with mental health issues.
Key features of the study:
- This report provides in-depth analysis of the U.K. drug for abuse testing device market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the U.K. drug for abuse testing device market based on the following parameters – Company Highlights, Product Types Portfolio, Key Highlights, Financial Performance, and Market Strategies
- Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The U.K. drug for abuse testing device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.K. drug for abuse testing device market
Detailed Segmentation:
- U.K. Drug for Abuse Testing Device Market, By Product Type:
- Immunoassay Analyzers
- Chromatography Instruments
- Breathalyzers
- Semiconductor-based Breathalyzer
- Infrared (IR) Based Breathalyzer
- Fuel Cell-based Breathalyzer
- Oral Fluid Testing Devices
- Urine Testing Devices
- Drug Testing Cups
- DIP Cards
- Drug Testing Cassettes
- Consumables
- Assay Kits
- Calibrators and Controls
- Others
- U.K. Drug for Abuse Testing Device Market, By Sample Type:
- Urine
- Breathe
- Saliva
- Hair
- Others
- U.K. Drug for Abuse Testing Device Market, By End user:
- Hospitals
- Federal Departments
- Rehabilitation Centers
- Diagnostic Laboratories
- Academic Institutes and Research Centers
- Others
- Company Profiles
- Abbott Laboratories*
- Company Highlights
- Product Types Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific, Inc
- Drägerwerk AG & Co. KGaA
- Laboratory Corporation of America Holdings
- Quest Diagnostics
- Alfa Scientific Designs, Inc
- Lifeloc Technologies Inc.
- Lion Laboratories Limited
- OraSure Technologies, Inc.
- Omega Laboratories, Inc.
- Shimadzu Corporation
- Siemens Healthineers
- F. Hoffmann-La Roche AG
- Premier Biotech, Inc.
- Psychemedics Corporation
- Innovative Testing Solutions
- Biopanda Reagents Ltd
- Alpha Laboratories
- Matrix Diagnostics
- Atlas Medical
- Rapid Labs Limited
- Randox Laboratories Ltd
* marked represents similar segmentation in other categories in the respective section.
